We identified ATF3/ATF4<sup>+</sup> endothelial cells (ECs) that exhibit altered angiogenic and immune regulatory profiles during PAD and confirmed that ATF4 signaling in ECs is required for effective ischemia recovery. This evidence concerns the gene ATF3 and peripheral arterial disease.